Partnership combines AbTherx's proprietary Atlas™ Long CDR3 Technology with GPCR Therapeutics' deep expertise in GPCR biology to discover and develop antibodies for novel targets MOUNTAIN VIEW, ...

The global Western Blotting Market is estimated to be valued at USD 909.5 million in 2025 and is projected to reach USD 1,567.9 million by 2035, registering a compound annual growth rate (CAGR) of 5.6 ...